Status:
COMPLETED
Technology-delivered Physical Activity Program for Adolescents With Type 1 Diabetes
Lead Sponsor:
University of Vermont
Collaborating Sponsors:
National Institute of General Medical Sciences (NIGMS)
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
This project is comprised of a two-arm randomized control trial (RCT) testing the feasibility, acceptability, and preliminary efficacy of a nationally scalable program, Activate, a 12-week, technology...
Detailed Description
Adolescents with type 1 diabetes and socioeconomic disadvantage experience significant health disparities in glycemic outcomes in adolescence and cardiovascular disease and diabetes-related death late...
Eligibility Criteria
Inclusion
- Aged 13-17 years old
- At least 18 months post-diagnosis for type 1 diabetes
- Parent reported moderate to no physical activity for adolescent
- Ability to complete measures and intervention program in English
- Access to broadband or cellular internet
- Resides in and receives healthcare in the United States
Exclusion
- Ward of state
- Active psychosis
- Severe medical or psychiatric illness that limit participation (including any contraindications for physical activity)
Key Trial Info
Start Date :
April 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2024
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT05319600
Start Date
April 18 2022
End Date
March 21 2024
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont
Burlington, Vermont, United States, 05401